China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott, given ...

However, RBC Capital has reiterated that Vertex could require stronger execution to adopt Alyftrek to justify the current ...

In the volatile biotech industry, it is easy to overlook small-cap medical device companies, particularly those that are not ...

China's biotechnology stocks have experienced a significant rally, outperforming AI, with a 60% surge since January due to ...

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid news that peer Eli Lilly ...

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

Xeris Biopharma Holdings is a company that has successfully launched products which are already generating revenue. Read why ...

The rally in the sector this year outpaces the 17% gain in China’s tech stocks that was driven by the release of DeepSeek’s ...

A Hong Kong company developing herbal treatments for ADHD has seen its stock price surge over 56,000% this year following a ...

Parataxis is launching a Bitcoin treasury platform for South Korean institutional investors, which saw Bridge Bio’s stock ...

Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...